Structure and biological activity of pathogen-like synthetic nanomedicines.

UNLABELLED Here we characterize the structure, stability and intracellular mode of action of DermaVir nanomedicine that is under clinical development for the treatment of HIV/AIDS. This nanomedicine comprises pathogen-like pDNA/PEIm nanoparticles (NPs) having the structure and function resembling spherical viruses that naturally evolved to deliver nucleic acids to the cells. Atomic force microscopy demonstrated spherical 100 - 200 nm NPs with a smooth polymer surface protecting the pDNA in the core. Optical absorption determined both the NP structural stability and biological activity relevant to their ability to escape from the endosome and release the pDNA at the nucleus. Salt, pH and temperature influence nanomedicine shelf-life and intracellular stability. This approach facilitates the development of diverse polyplex nanomedicines where the delivered pDNA-expressed antigens induce immune responses to kill infected cells. FROM THE CLINICAL EDITOR The authors investigated DermaVir nanomedicine comprised of pathogen-like pDNA/PEIm nanoparticles with structure and function resembling spherical viruses. DermaVir delivery of pDNA expresses antigens that induce immune responses to kill HIV infected cells.

[1]  Q. Fang,et al.  The heterogeneous nature of polyethylenimine-DNA complex formation affects transient gene expression , 2009, Cytotechnology.

[2]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[3]  D. Lauffenburger,et al.  Vector unpacking as a potential barrier for receptor-mediated polyplex gene delivery. , 2000, Biotechnology and bioengineering.

[4]  H. Lutz,et al.  The Role of Complement Activation in Hypersensitivity to Pegylated Liposomal Doxorubicin (Doxil®) , 2000 .

[5]  V. Parpura,et al.  Nanotechnology for Biology and Medicine , 2012, Fundamental Biomedical Technologies.

[6]  K. Mechtler,et al.  Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. , 1996, Human gene therapy.

[7]  Y. Barenholz,et al.  Electrostatic and structural properties of complexes involving plasmid DNA and cationic lipids commonly used for gene delivery. , 1998, Biochimica et biophysica acta.

[8]  M. Tóth,et al.  In vitro and in vivo complement activation and related anaphylactic effects associated with polyethylenimine and polyethylenimine-graft-poly(ethylene glycol) block copolymers. , 2011, Biomaterials.

[9]  J. Lisziewicz,et al.  DermaVir, a novel HIV immunisation technology. , 2005, Vaccine.

[10]  Y. Barenholz,et al.  Relationships between chemical composition, physical properties and transfection efficiency of polysaccharide-spermine conjugates. , 2006, Biomaterials.

[11]  G. Mao,et al.  DNA release dynamics from bioreducible poly(amido amine) polyplexes. , 2009, The journal of physical chemistry. B.

[12]  Leaf Huang,et al.  New structures in complex formation between DNA and cationic liposomes visualized by freeze—fracture electron microscopy , 1994, FEBS letters.

[13]  J. Lisziewicz,et al.  Induction of Potent Human Immunodeficiency Virus Type 1-Specific T-Cell-Restricted Immunity by Genetically Modified Dendritic Cells , 2001, Journal of Virology.

[14]  D. Crothers,et al.  Nucleic Acids: Structures, Properties, and Functions , 2000 .

[15]  A. Mikos,et al.  Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[16]  A. Hopkins,et al.  Interferon‐γ induces internalization of epithelial tight junction proteins via a macropinocytosis‐like process , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  Tae Gwan Park,et al.  Molecular design of functional polymers for gene therapy , 2007 .

[18]  W. Seeger,et al.  Modified polyethylenimines as non-viral gene delivery systems for aerosol gene therapy: investigations of the complex structure and stability during air-jet and ultrasonic nebulization. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[19]  D. Wirtz,et al.  Efficient active transport of gene nanocarriers to the cell nucleus , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[20]  B. Lobo,et al.  Isothermal titration calorimetric analysis of the interaction between cationic lipids and plasmid DNA. , 2001, Archives of biochemistry and biophysics.

[21]  J. Lisziewicz,et al.  DermaVir: a novel topical vaccine for HIV/AIDS. , 2005, The Journal of investigative dermatology.

[22]  J Szebeni,et al.  Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs: a model for pseudoallergic cardiopulmonary reactions to liposomes. Role of complement and inhibition by soluble CR1 and anti-C5a antibody. , 1999, Circulation.

[23]  G. Zuber,et al.  Towards synthetic viruses. , 2001, Advanced drug delivery reviews.

[24]  R. Garcea,et al.  Virus-like particles as vaccines and vessels for the delivery of small molecules. , 2004, Current opinion in biotechnology.

[25]  J. Lisziewicz,et al.  Control of viral rebound through therapeutic immunization with DermaVir , 2005, AIDS.

[26]  J. Lisziewicz,et al.  A plasmid DNA immunogen expressing fifteen protein antigens and complex virus-like particles (VLP+) mimicking naturally occurring HIV. , 2011, Vaccine.

[27]  Julianna Lisziewicz,et al.  Rational development of a stable liquid formulation for nanomedicine products. , 2010, International journal of pharmaceutics.

[28]  A. Karim,et al.  Characterization of non-equilibrium nanoparticle adsorption on a model biological substrate. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[29]  T. Reineke,et al.  Trehalose click polymers inhibit nanoparticle aggregation and promote pDNA delivery in serum. , 2006, Journal of the American Chemical Society.

[30]  Abdallah,et al.  Gene transfer with lipospermines and polyethylenimines. , 1998, Advanced drug delivery reviews.

[31]  Mary E. Hughes,et al.  Optical absorption of DNA-carbon nanotube structures. , 2007, Nano letters.

[32]  Peter E. Nielsen,et al.  Ionic Effects on the Stability and Conformation of Peptide Nucleic Acid Complexes , 1996 .

[33]  J. Irache,et al.  Mannose-targeted systems for the delivery of therapeutics. , 2008, Expert opinion on drug delivery.

[34]  David J. Leggett,et al.  Computational methods for the determination of formation constants , 1985 .

[35]  A. Dautry‐Varsat,et al.  Interleukin 2 receptors and detergent-resistant membrane domains define a clathrin-independent endocytic pathway. , 2001, Molecular cell.

[36]  F M Muggia,et al.  Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[37]  J. Lisziewicz,et al.  Rational Design of Formulated DNA Vaccines: The DermaVir Approach , 2012 .

[38]  F M Muggia,et al.  Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study. , 1998, Journal of the National Cancer Institute.

[39]  R. Langer,et al.  Exploring polyethylenimine‐mediated DNA transfection and the proton sponge hypothesis , 2005, The journal of gene medicine.